Reuters logo
BRIEF-Adocia and Lilly initiate phase 1b study evaluating Lispro U100
2016年1月29日 / 早上6点44分 / 2 年前

BRIEF-Adocia and Lilly initiate phase 1b study evaluating Lispro U100

Jan 29 (Reuters) - Adocia SA :

* Adocia and Eli Lilly and Co initiate phase 1b study evaluating ultra-rapid insulin biochaperone Lispro U100 in healthy Japanese subjects Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below